Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator DewDiligence
Search This Board:
Last Post: 10/20/2014 6:39:50 PM - Followers: 51 - Board type: Free - Posts Today: 9
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA
Current Price
Volume:
Bid Ask Day's Range
Wiki
News News Alert: Enanta Pharmaceuticals Provides Update on its Collaboration Agreement with AbbVie 10/20/2014 04:52:00 PM
PostSubject
#178  Sticky Note ENTA Valuation Model (revised as a consequence of DewDiligence 12/15/13 10:48:00 PM
#654   Sell-on-approval is a possibility, I suppose, but it DewDiligence 10/20/14 06:39:50 PM
#653   I had assumed a 35% (rather than 30%) DewDiligence 10/20/14 05:45:58 PM
#652   How does this valuation change based on the Double_Bagel 10/20/14 05:07:15 PM
#651   I have a great position in this (thanks biotech_researcher 10/20/14 04:52:45 PM
#650   New all-time intra-day ($47.00) and closing ($46.59) highs. DewDiligence 10/20/14 04:13:40 PM
#649   From ACG presentation on TURQUOISE-2 study: DewDiligence 10/20/14 03:57:12 PM
#648   HCV treatment breakthroughs highlighted at ACG 2014 stockbettor 10/20/14 01:34:57 PM
#645   GT1 trial of ABT-493/ABT-530 has 8of16 sites recruiting DewDiligence 10/19/14 11:25:34 AM
#644   Probably will not find out anything new, but stockbettor 10/17/14 06:18:27 PM
#643   Thank you. willyw 10/12/14 03:00:16 PM
#642   Is it possible that Abbvie 3D may DewDiligence 10/12/14 02:28:45 PM
#641   Is it possible that Abbvie 3D may be willyw 10/12/14 12:44:48 PM
#640   GILD’s Harvoni approved—why ENTA is up today: DewDiligence 10/10/14 02:50:22 PM
#639   FWIW - just say my 1st ABBV hep steveporsche 10/08/14 09:35:33 AM
#638   These are only called "high dose or low dose" willyw 10/02/14 12:00:23 PM
#637   What’s curious is that the GT1 trial has DewDiligence 10/02/14 11:09:49 AM
#636   Thoughts on 2nd Gen ABT-493 & ABT-530 willyw 10/02/14 10:54:59 AM
#635   One and the same, just less nuanced. EOM WorstLuck 10/01/14 02:08:49 PM
#634   Or the Market never ascribed any value for DewDiligence 10/01/14 01:55:32 PM
#633   It looks so far as though the market 10nisman 10/01/14 01:53:04 PM
#632   It looks so far as though the market WorstLuck 10/01/14 10:54:21 AM
#631   Correct—I just commented in #msg-106779255. Regards, Dew DewDiligence 10/01/14 09:43:10 AM
#630   Dew, I guess you could deduct $5 per steveporsche 10/01/14 09:29:07 AM
#629   Were I to guess who is correct, I willyw 09/26/14 08:37:52 PM
#628   I’m guessing 60 days because that’s what similar DewDiligence 09/26/14 07:35:00 PM
#627   IF that were to be the case, they willyw 09/26/14 03:18:24 PM
#626   My guess is the decision period is 60 DewDiligence 09/26/14 02:56:00 PM
#625   Thanks, I took some notes and recall him willyw 09/26/14 02:49:35 PM
#624   Jay Luly stated on the recent MS webcast DewDiligence 09/26/14 02:34:01 PM
#623   I thought that I would add to this willyw 09/26/14 02:29:37 PM
#622   I appreciate that. I have been busy with willyw 09/21/14 04:44:27 PM
#621   I posted the clinical-trial links with some annotations DewDiligence 09/18/14 08:55:48 PM
#620   Abbvie Enta 2nd generation trials now @ clinicaltrials willyw 09/18/14 02:35:18 PM
#619   Don't know if there will be a "short" linhdtu 09/18/14 10:06:02 AM
#618   Alan Dworsky reports 5.4% passive stake in Enanta… DewDiligence 09/18/14 09:45:06 AM
#617   Alan Dworsky reports 5.4% passive stake in Enanta Double_Bagel 09/18/14 08:18:27 AM
#616   RA Capital busted for shady dealings : linhdtu 09/17/14 09:08:03 PM
#615   It is my opinion that the FDA will oc631 09/16/14 08:00:07 PM
#614   ENTA’s CFO sold 10K shares yesterday under a DewDiligence 09/16/14 04:31:36 PM
#613   Rather early to call MRK's IDIX aquisition "excellent" frontiers 09/15/14 06:53:22 PM
#612   ACHN is being crushed today. biotech_researcher 09/15/14 03:33:13 PM
#611   $95-100K (for 12 weeks) is consistent with my DewDiligence 09/15/14 02:53:44 PM
#610   Balky payers, beware: Gilead eyes $95K-or-so price for steveporsche 09/15/14 02:22:45 PM
#609   I see your point about those Achn VCs linhdtu 09/15/14 12:24:10 PM
#608   It is my opinion that the FDA will linhdtu 09/15/14 12:17:42 PM
#607   Rather early to call MRK's IDIX aquisition "excellent" eh? pollyvonwog 09/15/14 08:36:35 AM
#606   What's presumptuous about making a factual statement. All frontiers 09/14/14 09:57:07 PM
#605   A presumptuous assertion!! ... so you think you oc631 09/14/14 06:52:08 PM
#604   We will see what happens. It is an willyw 09/14/14 12:06:22 PM
#603   My limited experience with these trials seems like willyw 09/13/14 09:42:22 PM
PostSubject